Evidence map›Paper›PMID 31655212›Full record

ArticleThe ocular surface2020

Investigation of factors associated with ABCB5-positive limbal stem cell isolation yields from human donors.

Yuzuru Sasamoto, Naoko Sasamoto, Johnathan Tran, Ananda Mishra, Bruce R Ksander, Markus H Frank, Natasha Y Frank

Abstract read
In one paragraph

Article in The ocular surface, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. MYEOV Is a Novel Marker of Differentiated Corneal Epithelium.Investigative ophthalmology & visual science · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Process development and safety evaluation of ABCB5Stem cell research & therapy · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuzuru SasamotoDivision of Genetics, Brigham and Women's Hospital, Boston, MA, United States.
Naoko SasamotoObstetrics and Gynecology Epidemiology Center, Department of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Johnathan TranDivision of Genetics, Brigham and Women's Hospital, Boston, MA, United States; Transplant Research Program, Boston Children's Hospital, Boston, MA, United States.
Ananda MishraDivision of Genetics, Brigham and Women's Hospital, Boston, MA, United States; Transplant Research Program, Boston Children's Hospital, Boston, MA, United States.
Bruce R KsanderMassachusetts Eye & Ear Infirmary, Schepens Eye Research Institute, Boston, MA, United States.
Markus H FrankTransplant Research Program, Boston Children's Hospital, Boston, MA, United States; Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA; Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA; School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.
Natasha Y FrankDepartment of Medicine, VA Boston Healthcare System, Boston, MA, United States; Division of Genetics, Brigham and Women's Hospital, Boston, MA, United States; Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA. Electronic address: nyfrank@bwh.harvard.edu.

Funding

VISION RESEARCHP30EY003790 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI Tobias Elze · 1985 to 2026
$25.5M
ABCB5-positive stem cells for LSCD therapyR01EY025794 · NEI · BOSTON CHILDREN'S HOSPITAL · PI NATASHA Y FRANK, Markus H. Frank · 2016 to 2026
$6.1M
Multipotent ABCB5-positive cell therapeutics for corneal diseaseR24EY028767 · NEI · BRIGHAM AND WOMEN'S HOSPITAL · PI FRANK, MARKUS H., FRANK, NATASHA Y · 2018 to 2022
$5.9M
ABCB5+ Dermal Stem Cells In Regenerative Wound HealingI01RX000989 · VA · VA BOSTON HEALTH CARE SYSTEM · PI FRANK, NATASHA Y · 2015 to 2017
–
NEI NIH HHS P30 EY003790NEI NIH HHS R01 EY025794NEI NIH HHS R24 EY028767RRD VA I01 RX000989
6 · The paper itself

Abstract

purposeTo identify factors associated with isolation yields of ATP-binding cassette (ABC) superfamily member B5 (ABCB5)-positive limbal stem cells (LSCs) from human cadaveric donor eyes.

methodsWhole eye globes were obtained from the Saving Sight eye bank, Kansas City, MO and the CorneaGen eye bank, Seattle, WA. ABCB5-positive LSCs were sorted by flow cytometry upon anti-ABCB5 monoclonal antibody staining within one week after donor death. The yields of live limbal epithelial cells in their entirety and of isolated pure ABCB5-positive LSC subsets were correlated with variables contained in the eye donors' medical information.

resultsThe mean isolation yield of live limbal epithelial cells and ABCB5-positive LSCs per donor eye was (340,000 ± 160,000 and 2,608 ± 1,842 respectively, mean ± SD). Stepwise regression analysis showed that cardiac disease-related death was the strongest negative predictor of the ABCB5-positive LSC isolation yield (p = 0.01). While we observed a trend for an age-related decline in the yield of ABCB5-positive LSCs, a statistically significant association could not be established (2% decrease/year, p = 0.11). Additionally, despite a trend for decreased isolation yields of total live limbal epithelial cells isolated from single donors with a longer time between death and tissue processing (p = 0.04), this did not affect the yields of purified ABCB5-positive LSC, which was independent of increasing time between death and tissue processing (p = 0.50).

conclusionsOur study identifies cardiac disease-related death as a donor variable significantly associated with lower ABCB5-positive LSC isolation yields.

Indexed as

Epithelium, CornealStem CellsAgedAged, 80 and overATP Binding Cassette Transporter, Subfamily BCell SeparationEpithelial CellsFemaleHumansLimbus CorneaeMaleMiddle AgedTissue DonorsABCB5 protein, humanATP Binding Cassette Transporter, Subfamily BABCB5Corneal blindnessLimbal stem cell deficiencyLimbal stem cell isolationLimbal stem cells

Identifiers

PMID31655212
PMCPMC7840156

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.